PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93021P01385OPTION YEAR 1. license FROM advanced — Advanced Bioadjuvants, LLC

Advanced Bioadjuvants, LLC holds $75K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 25, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Institutes Of Health Niaid

Awarding office

Advanced Bioadjuvants, LLC

Recipient

Sep 25, 2024

PoP end

$150K

Obligated

$375K

Potential

541714

NAICS

AN11

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Advanced Bioadjuvants, LLC — $90

Contract facts

NONE

Contract number75N93021P01385

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAdvanced Bioadjuvants, LLC

CAGE63B17

UEIF9TBLFL9A3C3

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11

Place of performanceOMAHA NE

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationNIAID_NOI21_2063418

PoP startSep 26, 2021

PoP end (current)Sep 25, 2024

PoP end (w/ options)Sep 25, 2026

Obligated$150K

Current value$225K

Potential value$375K

OPTION YEAR 1. LICENSE FROM ADVANCED BIOADJUVANTS LLC TO PRODUCE THEIR PATENTED ADJUPLEX ADJUVANTS. (AMBIS #2063418 & 2122404) is a federal NONE award for National Institutes Of Health Niaid held by Advanced Bioadjuvants, LLC. Estimated value $375K ($150K obligated). Current period of performance ends Sep 25, 2024 (potential Sep 25, 2026). Last award drew 1 bidder. Place of performance: OMAHA NE. Related solicitation NIAID_NOI21_2063418.

OPTION YEAR 1. LICENSE FROM ADVANCED BIOADJUVANTS LLC TO PRODUCE THEIR PATENTED ADJUPLEX ADJUVANTS. (AMBIS #2063418 & 2122404)

Recompete timing

Public

● Past PoP end (694 days ago)

Current PoP ended Sep 25, 2024 (694 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Advanced Bioadjuvants, LLC — $75K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$75K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N93021P01385?

75N93021P01385 (OPTION YEAR 1. license FROM advanced) is a National Institutes Of Health Niaid award with a potential value of $375K, currently held by Advanced Bioadjuvants, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93021P01385?

National Institutes Of Health Niaid awarded 75N93021P01385 to Advanced Bioadjuvants, LLC (potential $375K).

Who is the incumbent on 75N93021P01385?

Advanced Bioadjuvants, LLC is the incumbent with $75K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 25, 2024.

When does Advanced Bioadjuvants, LLC’s 75N93021P01385 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 25, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 11, 2023